ALL KEYWORDS
Triple-Negative Breast Cancer
Related Specialists
Showing 3 of 6
Related Clinical Trials
Showing 2 of 7
Shorter Anthracycline-Free Chemo Immunotherapy Adapted to Pathological Response in Early Triple Negative Breast Cancer (SCARLET), A Randomized Phase III Study
- Breast Cancer
OptimICE-PCR: De-Escalation of Therapy in Early-Stage TNBC Patients Who Achieve pCR After Neoadjuvant Chemotherapy With Checkpoint Inhibitor Therapy
- Breast Cancer
Related News
Related Departments
Showing 3 of 25